A A Fox - JoVE Visualize

Showing results (71-80 of 491) with videos related to

Pageof 50

Sort By:

Journal of the American College of Cardiology|January 18, 2005

Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3)Joseph Kim, Robert A Henderson, Stuart J Pocock, et al.

Hypertension (Dallas, Tex. : 1979)|October 20, 2004

Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibitionNicholas L M Cruden, Keith A A Fox, Christopher A Ludlam, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|April 24, 2004

Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failureNicholas L M Cruden, Fraser N Witherow, David J Webb, et al.

Thrombosis Research|September 23, 2011

Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markersA Burdess, A E Michelsen, F Brosstad, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2003

Bradykinin receptor antagonism and endothelial tissue plasminogen activator release in humansFraser N Witherow, Pamela Dawson, Christopher A Ludlam, et al.

Alimentary Pharmacology & Therapeutics|July 2, 2024

Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low-dose rivaroxaban, or the combination: Secondary analysis of the COMPASS randomised controlled trialNauzer Forbes, Qilong Yi, Paul Moayyedi, et al.

JACC. Cardiovascular Interventions|May 26, 2009

Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events)Caroline Medi, Gilles Montalescot, Andrzej Budaj, et al.

Circulation|August 18, 2004

Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) TrialKeith A A Fox, Shamir R Mehta, Ron Peters, et al.

Heart (British Cardiac Society)|May 20, 2006

Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparinS A Harding, J N Din, J Sarma, et al.

European Heart Journal|July 20, 2002

Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE)K A A Fox, S G Goodman, W Klein, et al.

Pageof 50

Showing results (71-80 of 491) with videos related to

Sort By:

Pageof 50

Journal of the American College of Cardiology|January 18, 2005

Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3)Joseph Kim, Robert A Henderson, Stuart J Pocock, et al.

Hypertension (Dallas, Tex. : 1979)|October 20, 2004

Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibitionNicholas L M Cruden, Keith A A Fox, Christopher A Ludlam, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|April 24, 2004

Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failureNicholas L M Cruden, Fraser N Witherow, David J Webb, et al.

Thrombosis Research|September 23, 2011

Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markersA Burdess, A E Michelsen, F Brosstad, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2003

Bradykinin receptor antagonism and endothelial tissue plasminogen activator release in humansFraser N Witherow, Pamela Dawson, Christopher A Ludlam, et al.

Alimentary Pharmacology & Therapeutics|July 2, 2024

Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low-dose rivaroxaban, or the combination: Secondary analysis of the COMPASS randomised controlled trialNauzer Forbes, Qilong Yi, Paul Moayyedi, et al.

JACC. Cardiovascular Interventions|May 26, 2009

Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events)Caroline Medi, Gilles Montalescot, Andrzej Budaj, et al.

Circulation|August 18, 2004

Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) TrialKeith A A Fox, Shamir R Mehta, Ron Peters, et al.

Heart (British Cardiac Society)|May 20, 2006

Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparinS A Harding, J N Din, J Sarma, et al.

European Heart Journal|July 20, 2002

Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE)K A A Fox, S G Goodman, W Klein, et al.

Pageof 50